Figures & data
Figure 1. Incident non-AIDS-defining diseases. Cross-section of number of patients with different comorbidities of non-AIDS-defining diseases between 2010 and 2019, based on observed 299 patients who developed non-AIDS-defining diseases (each square represents a patient) (A). Incidences of various comorbidities of non-AIDS-defining diseases between 2010 and 2019 (B). ARD: Advanced renal disease. CVD: cardiovascular disease. ESLD: end-stage liver disease. NADC: non-AIDS-defining cancer. NADs: non-AIDS-defining diseases.
Table 1. Demographic characteristics and prevalence of modifiable factors in participants with or without NADs.
Figure 2. Population attributable fractions for traditional and HIV-related risk factors for cardiovascular diseases. Whiskers indicate 95% CI. Below the plot, prevalence is the prevalence of the risk factor at study entry among those with incident cardiovascular diseases. aHRs were adjusted for age and sex. aHR: adjusted hazard ratio. ART: antiretroviral therapy. eGFR: estimated glomerular filtration rate. BMI: body-mass index. HCV: hepatitis C virus.
Figure 3. Population attributable fractions for traditional and HIV-related risk factors for end-stage liver disease. Whiskers indicate 95% CI. Below the plot, prevalence is the prevalence of the risk factor at study entry among those with incident end-stage liver diseases. aHRs were adjusted for age and sex. aHR: adjusted hazard ratio. ART: antiretroviral therapy. BMI: body-mass index. HBV: hepatitis B virus. HCV: hepatitis C virus.
Figure 4. Population attributable fractions for traditional and HIV-related risk factors for advanced renal disease. Whiskers indicate 95% CI. Below the plot, prevalence is the prevalence of the risk factor at study entry among those with incident advanced renal diseases. aHRs were adjusted for age and sex. aHR: adjusted hazard ratio. ART: antiretroviral therapy. eGFR: estimated glomerular filtration rate. HCV: hepatitis C virus.
